Two senior Wall Street executives complained this week that over-regulation is discouraging initial public offerings.

The company’s upsized offering is a hopeful sign for venture investors in the sector.

Shiv Texchem IPO allotment has been finalised today, October 11. Investors can check their allotment status on Link Intime's ...

Upstream Bio has swollen its IPO to $255 million as the company joins CAMP4 Therapeutics this morning in becoming the latest ...

Cerebras is playing in a huge market with insatiable investor demand, but its IPO prospectus is littered with red flags that ...

Two biotechs set out for the public markets this week, with Upstream Bio raising $255 million for its inflammatory disease ...

The initial public offering of Europe’s largest chain of convenience stores, Zabka Group SA, is priced at the top of a ...

Hyundai Motor plans to use proceeds from a record $3.3 billion IPO of its Indian unit to enhance its research efforts and ...

Drinks maker China Resources Beverage is set to launch its Hong Kong initial public offering (IPO) next week, aiming to raise ...

Ceribell Inc. launched its initial public offering of more than 10.6 million shares of common stock at $17 and steadily saw ...

BlackRock Inc., Singaporean sovereign wealth fund GIC Pte and Capital Group are among those that have made bids to buy stock ...

CeriBell announced that it priced an upsized initial public offering (IPO), expecting proceeds of approximately $180.3 ...